EU Regulatory Rep for Medical Devices & IVD
Elpisia Europe supports manufacturers with EU regulatory representation and compliance coordination for selected medical devices and IVD products.
We assist with authority communication, documentation readiness, and post-market regulatory support to help companies manage European regulatory requirements more efficiently.
EU Authorized Rep Support (EU-REP / EC-REP)
Elpisia Europe supports non-EU medical device and IVD manufacturers with practical EU regulatory representation and compliance coordination under MDR and IVDR requirements.
Our services may include support for regulatory communication, documentation readiness, EUDAMED-related coordination, and post-market regulatory assistance to help businesses manage European market access more efficiently.
Structured Regulatory Support for Your European Expansion
Elpisia Europe provides a transparent and practical workflow to support manufacturers throughout their European market journey — from initial assessment and onboarding to ongoing compliance coordination.
We conduct an initial review of your product profile, intended use, and available documentation to help determine applicable regulations and support a clearer pathway toward European market access.
Once the project scope is confirmed, Elpisia Europe assists clients with the onboarding process and applicable regulatory representation arrangements for the European market.
We provide practical guidance on documentation requirements, regulatory responsibilities, and next steps to support smoother market access preparation.
We review available technical documentation and labeling information to support regulatory readiness for the applicable European requirements.
This may include checking key product information, labeling elements, and regulatory representation details where applicable.
We provide ongoing support relating to regulatory coordination and communication processes associated with applicable European requirements, including assistance with documentation follow-up and post-market regulatory matters where applicable.
Elpisia Europe provides ongoing support to help clients stay informed about relevant European regulatory developments and potential compliance updates affecting their products and market access activities.
Why Elpisia Europe
Helping businesses navigate European regulations with responsive and practical compliance support.
Elpisia Europe operates from within the European Union and aims to maintain practical internal processes supporting confidentiality, document handling, and regulatory coordination activities.
We believe responsive communication and clear coordination are important for successful regulatory projects. Our team aims to keep clients informed throughout the engagement process.
Elpisia Europe supports manufacturers with practical regulatory coordination and ongoing compliance assistance for both single-market entry projects and broader regional expansion activities.
Frequently asked Questions
An EU Authorized Representative (EU-REP / EC-REP) is an organization established within the European Union that is formally appointed by a non-EU manufacturer to support certain regulatory obligations relating to products placed on the European market.
Under applicable European regulations such as MDR 2017/745 and IVDR 2017/746, non-EU manufacturers of medical devices and IVD products generally require an EU-based Authorized Representative before placing products on the EU market.
Depending on the applicable regulatory framework and agreed scope of service, an EU Authorized Representative may assist with regulatory communication support, documentation availability, EUDAMED-related coordination, and certain post-market regulatory processes.
The required documentation depends on the product category, classification, and applicable European regulations. Manufacturers are generally expected to maintain technical and regulatory documentation supporting product compliance for the European market.
Typical documentation may include product information, intended use, labeling, IFU, quality-related documents, risk management records, and applicable clinical or performance documentation where relevant.
As part of the regulatory representation process, Elpisia Europe may assist with certain regulatory communication and coordination activities relating to products placed on the European market.
Where applicable, we support clients with communication follow-up, documentation coordination, and practical regulatory assistance relating to post-market and compliance-related matters under the agreed project scope.
Applicable European regulations may require certain Authorized Representative details to appear on product labeling and accompanying documentation where relevant.
Incomplete or missing regulatory information could potentially affect compliance status or market access activities. Elpisia Europe may assist clients with practical review of labeling and documentation requirements relating to regulatory representation support.
After a product is placed on the European market, manufacturers are generally expected to maintain ongoing compliance with applicable regulatory requirements.
This may include maintaining updated documentation, monitoring post-market information, reviewing labeling and regulatory changes, and managing applicable post-market or vigilance-related activities where relevant.